A share price of Rockwell Medical Inc [RMTI] is currently trading at $1.05, up 0.48%. An important factor to consider is whether the stock is rising or falling in short-term value. The RMTI shares have gain 7.14% over the last week, with a monthly amount drifted -1.87%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rockwell Medical Inc [NASDAQ: RMTI] stock has seen the most recent analyst activity on November 14, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $5. Previously, Piper Jaffray started tracking the stock with Overweight rating on June 24, 2019, and set its price target to $10. On May 13, 2019, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock. BofA/Merrill downgraded its rating to a Underperform. Stifel downgraded its rating to a Hold. Morgan Stanley started tracking with a Underweight rating for this stock on August 13, 2015, and assigned it a price target of $7. In a note dated January 27, 2015, Oppenheimer reiterated an Outperform rating on this stock and boosted its target price from $24 to $26.
Rockwell Medical Inc experienced fluctuations in its stock price throughout the past year between $0.78 and $5.15. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Rockwell Medical Inc [NASDAQ: RMTI] shares were valued at $1.05 at the most recent close of the market. An investor can expect a potential return of 185.71% based on the average RMTI price forecast.
Analyzing the RMTI fundamentals
Trailing Twelve Months sales for Rockwell Medical Inc [NASDAQ:RMTI] were 97.73M which represents -16.59% decline. Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.07 and Total Capital is -0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9533 points at the first support level, and at 0.8567 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1533, and for the 2nd resistance point, it is at 1.2567.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rockwell Medical Inc [NASDAQ:RMTI] is 2.95. On the other hand, the Quick Ratio is 2.50, and the Cash Ratio is 1.14. Considering the valuation of this stock, the price to sales ratio is 0.37, the price to book ratio is 1.14.
Transactions by insiders
Recent insider trading involved Chole Timothy, SVP and CCO, that happened on Jul 01 ’25 when 2868.0 shares were sold. SVP and CFO, Neri Jesse completed a deal on Jul 01 ’25 to sell 886.0 shares. Meanwhile, President and CEO Strobeck Mark sold 6926.0 shares on Jul 01 ’25.
